Clinical characteristics of children and young people admitted to hospital with covid-19 in United Kingdom: prospective multicentre observational cohort study
Objective
To characterise the clinical features of children and young people admitted to hospital with laboratory confirmed severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in the UK and explore factors associated with admission to critical care, mortality, and development of multisystem inflammatory syndrome in children and adolescents temporarily related to coronavirus disease 2019 (covid-19) (MIS-C).
Design
Prospective observational cohort study with rapid data gathering and near real time analysis.
Setting
260 hospitals in England, Wales, and Scotland between 17 January and 3 July 2020, with a minimum follow-up time of two weeks (to 17 July 2020).
Participants
651 children and young people aged less than 19 years admitted to 138 hospitals and enrolled into the International Severe Acute Respiratory and emergency Infections Consortium (ISARIC) WHO Clinical Characterisation Protocol UK study with laboratory confirmed SARS-CoV-2.
Main outcome measures
Admission to critical care (high dependency or intensive care), in-hospital mortality, or meeting the WHO preliminary case definition for MIS-C.
Results
Median age was 4.6 (interquartile range 0.3-13.7) years, 35% (225/651) were under 12 months old, and 56% (367/650) were male. 57% (330/576) were white, 12% (67/576) South Asian, and 10% (56/576) black. 42% (276/651) had at least one recorded comorbidity. A systemic mucocutaneous-enteric cluster of symptoms was identified, which encompassed the symptoms for the WHO MIS-C criteria. 18% (116/632) of children were admitted to critical care. On multivariable analysis, this was associated with age under 1 month (odds ratio 3.21, 95% confidence interval 1.36 to 7.66; P=0.008), age 10-14 years (3.23, 1.55 to 6.99; P=0.002), and black ethnicity (2.82, 1.41 to 5.57; P=0.003). Six (1%) of 627 patients died in hospital, all of whom had profound comorbidity. 11% (52/456) met the WHO MIS-C criteria, with the first patient developing symptoms in mid-March. Children meeting MIS-C criteria were older (median age 10.7 (8.3-14.1) v 1.6 (0.2-12.9) years; P<0.001) and more likely to be of non-white ethnicity (64% (29/45) v 42% (148/355); P=0.004). Children with MIS-C were five times more likely to be admitted to critical care (73% (38/52) v 15% (62/404); P<0.001). In addition to the WHO criteria, children with MIS-C were more likely to present with fatigue (51% (24/47) v 28% (86/302); P=0.004), headache (34% (16/47) v 10% (26/263); P<0.001), myalgia (34% (15/44) v 8% (21/270); P<0.001), sore throat (30% (14/47) v (12% (34/284); P=0.003), and lymphadenopathy (20% (9/46) v 3% (10/318); P<0.001) and to have a platelet count of less than 150 × 10 9 /L (32% (16/50) v 11% (38/348); P<0.001) than children who did not have MIS-C. No deaths occurred in the MIS-C group.
Conclusions
Children and young people have less severe acute covid-19 than adults. A systemic mucocutaneous-enteric symptom cluster was also identified in acute cases that shares features with MIS-C. This study provides additional evidence for refining the WHO MIS-C preliminary case definition. Children meeting the MIS-C criteria have different demographic and clinical features depending on whether they have acute SARS-CoV-2 infection (polymerase chain reaction positive) or are post-acute (antibody positive).
Study registration
ISRCTN66726260.
Top-30
Journals
|
2
4
6
8
10
12
14
16
|
|
|
Frontiers in Pediatrics
15 publications, 3.32%
|
|
|
Archives of Disease in Childhood
14 publications, 3.1%
|
|
|
Children
9 publications, 1.99%
|
|
|
BMJ
9 publications, 1.99%
|
|
|
Pediatric Infectious Disease Journal
8 publications, 1.77%
|
|
|
European Journal of Pediatrics
7 publications, 1.55%
|
|
|
Pediatric Research
7 publications, 1.55%
|
|
|
Pediatric Pulmonology
7 publications, 1.55%
|
|
|
Pediatrics
6 publications, 1.33%
|
|
|
Journal of Clinical Medicine
6 publications, 1.33%
|
|
|
Frontiers in Public Health
6 publications, 1.33%
|
|
|
Scientific Reports
6 publications, 1.33%
|
|
|
BMJ Open
6 publications, 1.33%
|
|
|
Viruses
5 publications, 1.11%
|
|
|
Cardiology in the Young
5 publications, 1.11%
|
|
|
Journal of Pediatrics
4 publications, 0.88%
|
|
|
PLoS ONE
4 publications, 0.88%
|
|
|
Journal of the Pediatric Infectious Diseases Society
4 publications, 0.88%
|
|
|
BMJ Paediatrics Open
4 publications, 0.88%
|
|
|
CMAJ
4 publications, 0.88%
|
|
|
NeoReviews
3 publications, 0.66%
|
|
|
Nature Medicine
3 publications, 0.66%
|
|
|
Pediatric Critical Care Medicine
3 publications, 0.66%
|
|
|
International Journal of Environmental Research and Public Health
3 publications, 0.66%
|
|
|
Frontiers in Medicine
3 publications, 0.66%
|
|
|
BMC Infectious Diseases
3 publications, 0.66%
|
|
|
EClinicalMedicine
3 publications, 0.66%
|
|
|
Jornal de Pediatria
3 publications, 0.66%
|
|
|
Journal of Pediatric Intensive Care
3 publications, 0.66%
|
|
|
2
4
6
8
10
12
14
16
|
Publishers
|
10
20
30
40
50
60
70
|
|
|
Springer Nature
64 publications, 14.16%
|
|
|
Elsevier
49 publications, 10.84%
|
|
|
Cold Spring Harbor Laboratory
40 publications, 8.85%
|
|
|
BMJ
39 publications, 8.63%
|
|
|
MDPI
36 publications, 7.96%
|
|
|
Ovid Technologies (Wolters Kluwer Health)
29 publications, 6.42%
|
|
|
Frontiers Media S.A.
29 publications, 6.42%
|
|
|
Wiley
27 publications, 5.97%
|
|
|
Oxford University Press
11 publications, 2.43%
|
|
|
American Academy of Pediatrics
10 publications, 2.21%
|
|
|
Georg Thieme Verlag KG
7 publications, 1.55%
|
|
|
American Medical Association (AMA)
7 publications, 1.55%
|
|
|
Cambridge University Press
6 publications, 1.33%
|
|
|
Public Library of Science (PLoS)
6 publications, 1.33%
|
|
|
Taylor & Francis
6 publications, 1.33%
|
|
|
AME Publishing Company
5 publications, 1.11%
|
|
|
European Respiratory Society (ERS)
4 publications, 0.88%
|
|
|
SciELO
4 publications, 0.88%
|
|
|
CMA Impact Inc.
4 publications, 0.88%
|
|
|
Jaypee Brothers Medical Publishing
3 publications, 0.66%
|
|
|
Bentham Science Publishers Ltd.
2 publications, 0.44%
|
|
|
F1000 Research
2 publications, 0.44%
|
|
|
PeerJ
2 publications, 0.44%
|
|
|
SAGE
2 publications, 0.44%
|
|
|
Walter de Gruyter
2 publications, 0.44%
|
|
|
International Global Health Society
2 publications, 0.44%
|
|
|
American Association for the Advancement of Science (AAAS)
2 publications, 0.44%
|
|
|
Hindawi Limited
2 publications, 0.44%
|
|
|
10
20
30
40
50
60
70
|
- We do not take into account publications without a DOI.
- Statistics recalculated weekly.